NEOS Investment Management LLC Increases Position in Stryker Corporation $SYK

NEOS Investment Management LLC increased its holdings in Stryker Corporation (NYSE:SYK) by 12.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 55,637 shares of the medical technology company’s stock after purchasing an additional 6,146 shares during the quarter. NEOS Investment Management LLC’s holdings in Stryker were worth $17,517,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. State Street Corp lifted its position in shares of Stryker by 2.1% during the 4th quarter. State Street Corp now owns 15,254,407 shares of the medical technology company’s stock valued at $5,374,731,000 after buying an additional 311,507 shares in the last quarter. Wellington Management Group LLP increased its holdings in Stryker by 0.6% in the 2nd quarter. Wellington Management Group LLP now owns 8,167,185 shares of the medical technology company’s stock worth $2,571,357,000 after acquiring an additional 45,478 shares in the last quarter. Geode Capital Management LLC raised its position in Stryker by 0.9% during the fourth quarter. Geode Capital Management LLC now owns 7,535,572 shares of the medical technology company’s stock worth $2,636,238,000 after acquiring an additional 69,851 shares during the period. Norges Bank acquired a new position in Stryker during the fourth quarter worth $1,822,272,000. Finally, Bank of America Corp DE purchased a new position in Stryker during the second quarter valued at $1,404,284,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Stryker

In other Stryker news, Director Ronda Stryker sold 50,000 shares of the firm’s stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $340.10, for a total value of $17,005,000.00. Following the completion of the sale, the director directly owned 2,251,375 shares of the company’s stock, valued at $765,692,637.50. This trade represents a 2.17% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Debra King sold 826 shares of Stryker stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the transaction, the insider owned 6,210 shares in the company, valued at approximately $2,088,423. This represents a 11.74% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 351,267 shares of company stock worth $118,197,701 in the last three months. 4.60% of the stock is owned by corporate insiders.

Stryker Price Performance

Shares of NYSE SYK opened at $302.92 on Friday. The firm has a 50-day simple moving average of $328.84 and a 200-day simple moving average of $329.73. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. The stock has a market capitalization of $116.19 billion, a price-to-earnings ratio of 31.39, a price-to-earnings-growth ratio of 1.93 and a beta of 0.76. Stryker Corporation has a 52 week low of $281.00 and a 52 week high of $396.37.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, topping the consensus estimate of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The business had revenue of $6.59 billion for the quarter, compared to analysts’ expectations of $6.58 billion. During the same period in the previous year, the firm posted $3.13 EPS. The business’s revenue for the quarter was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, equities analysts predict that Stryker Corporation will post 15.03 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.88 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.2%. Stryker’s payout ratio is 36.48%.

Wall Street Analysts Forecast Growth

SYK has been the subject of a number of research reports. Wall Street Zen raised shares of Stryker from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. BMO Capital Markets started coverage on shares of Stryker in a research note on Wednesday, July 8th. They issued an “outperform” rating and a $369.00 price target on the stock. BTIG Research cut their price objective on Stryker from $371.00 to $358.00 and set a “buy” rating for the company in a research note on Friday, July 31st. Weiss Ratings reissued a “hold (c)” rating on shares of Stryker in a report on Friday, July 31st. Finally, Royal Bank Of Canada decreased their target price on Stryker from $435.00 to $420.00 and set an “outperform” rating on the stock in a research report on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, Stryker currently has a consensus rating of “Moderate Buy” and an average price target of $386.28.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.